medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2012, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (3)

Bullous systemic lupus erythematosus: Case report and literature review

Sánchez NLM, Poletti ED, López DNV, Socorro LS, Sánchez DMA

Language: Spanish
References: 30
Page: 182-187
PDF size: 289.77 Kb.


ABSTRACT

Bullous lesions can rarely be present on the course of systemic lupus erythematosus (SLE), and the frequency is 0.04-8%. During pregnancy lupus activity can exacerbate in 20-40% of cases, usually one month after postpartum. We present the case of a 21 year-old female which developed vesicles and bullous lesions on her late puerperium, with clinical and histopathology findings of bullous SLE. She had remission of the clinical lesions after suppression of lupus activity


REFERENCES

  1. Gilliam JN, Sontheimer RD. “Skin manifestations of SLE”. Clin Rheum Dis. 1982; 8: 207-218.

  2. Klein RS, Morganroth PA, Werth VP. “Cutaneous lupus and the cutaneous lupus erythematosus disease area and severity index instrument”. Rheum Dis Clin North Am. 2010; 36(1): 33-51.

  3. Wong SN, Chua SH. “Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: A 2-year review”. Br J Dermatol. 2002; 147(3): 476-480.

  4. Grönhagen CM, Fored CM, Granath F, Nyberg F. “Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: A population-based cohort of 1 088 patients in Sweden”. Br J Dermatol. 2011; 164(6): 1335-1341.

  5. Vassileva S. “Bullous systemic lupus erythematosus”. Clin Dermatol. 2004; 2: 129-138.

  6. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J et al. “Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies”. Br J Rheumatol. 1996; 35(2): 133-138.

  7. Smyth A, Oliveira GH, Lahr BD, Bailey KR et al. “A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis”. Clin J Am Soc Nephrol. 2010; 5(11): 2060-2068.

  8. Sociedad Argentina de Dermatología. Consenso sobre diagnóstico y tratamiento de lupus eritematoso. 2006; 10, 25-26.

  9. Ng YY, Chang IT, Chen TW, Liou HN et al. “Concomitant lupus nephritis and bullous eruption in systemic lupus erythematosus”. Nephrol Dial Transplant. Julio, 1999; 14(7): 1739-1743.

  10. Pedro SD, Dahl MV. “Direct immunofluorescence of bullous systemic lupus erythematosus”. Arch Dermatol. 1993; 107: 118-20.

  11. Hall RP, Lawley TJ, Smith HR, Katz SI. “Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy”. Ann Intern Med. 1982; 97(2): 165-170.

  12. Camisa C, Sharma HM. “Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature”. J Am Acad Dermatol. 1983; 9(6): 924-933.

  13. Bernard P, Vaillant L, Labeille B et al. “Incidence and distribution of subepidermal autoimmune bullous skin disease in three French regions”. Arch Dermatol. 1995; 131: 48-52.

  14. Gammon WR, Woodley DT, Dole KC et al. “Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen”. J Invest Dermatol. 1985; 84(6): 472-476.

  15. Chen M, Chan LS, Cai X, O’Toole EA et al. “Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita”. J Invest Dermatol. 1997; 108(1): 68-72.

  16. González F, Sáenz AM, Cirocco A, Pérez C et al. “Lupus eritematoso en niños: presentaciones inusuales, revisión de la literatura”. Dermatol Pediatr Lat. 2003; 1(1): 30-35.

  17. Yell JA, Allen J, Wojnarowska F, Kirtschig G, Burge SM. “Bullous systemic lupus erythematosus: Revised criteria for diagnosis”. Br J Dermatol. 1995; 132(6): 921-928.

  18. Ting W, Stone MS, Racila D, Scofield RH et al. “Toxic epidermal necrolysis- like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): A case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions”. Lupus. 2004; 13(12): 941-950.

  19. Crowson AN, Magro C. “The cutaneous pathology of lupus erythematosus: A review”. J Cutan Pathol. 2001; 28(1): 1-23.

  20. Rappersberger K, Tschachler E, Tani M, Wolff K. “Bullous disease in systemic lupus erythematosus”. J Am Acad Dermatol. 1989; 21(4 Pt 1): 745-752.

  21. Hernández Bernardino G, Sánchez Navarro LM y cols. “Lupus eritematoso sistémico. Manifestaciones clínicas en 31 pacientes hospitalizados”. Dermatología CMQ. 2007; 5(4): 188-194.

  22. Uribe AG, Vilá LM, McGwin G Jr, Sanchez ML et al. “The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus”. J Rheumatol. 2004; 31(10): 1934-1940.

  23. Shirahama S, Yagi H, Furukawa F, Takigawa M. “A case of bullous systemic lupus erythematosus”. Dermatology. 1994; 189 (Suppl 1): 95-96.

  24. Burrows NP, Bhogal BS, Black MM, Rustin MH et al. “Bullous eruption of systemic lupus erythematosus: A clinicopathological study of four cases”. Br J Dermatol. 1993; 128(3): 332-338.

  25. Malcangi G, Brandozzi G, Giangiacomi M, Zampetti M, Danieli MG. “Bullous SLE: Response to methotrexate and relationship with disease activity”. Lupus. 2003; 12(1): 63-66.

  26. Sáez-de-Ocariz M, Espinosa-Rosales F, López-Corella E. “Bullous lesions as a manifestation of systemic lupus erythematosus in two Mexican teenagers”. Pediatr Rheumatol Online J. 2010; 8:19.

  27. Miniño M. “Índice de actividad lúpica y tratamiento del lupus eritematoso en dermatología”. Dermatología Rev Mex. 2008; 52(1): 20-28.

  28. Kurmar S, Agarwal I. “Unusual presentation of childhood systemic lupus erythematosus”. Pediatr Rheumatol Online J. 2007; 21(5): 20.

  29. González LA, Restrepo M, Vásquez G. “Lupus eritematoso sistémico ampolloso: dramática respuesta a la terapia con dapsona”. Rev Colomb Reumatol. 2009, 16(4): 352-360.

  30. Andrade OL, Irazoque PF, López VR, Barragán NY et al. “Eficacia de rituximab comparado con ciclofosfamida en pacientes con manifestaciones graves de lupus eritematoso generalizado. Estudio aleatorizado y multicéntrico”. Reumatol Clin. 2010t; 6(5): 250-255.




2020     |     www.medigraphic.com